Copyright
©The Author(s) 2004.
World J Gastroenterol. Oct 15, 2004; 10(20): 3011-3015
Published online Oct 15, 2004. doi: 10.3748/wjg.v10.i20.3011
Published online Oct 15, 2004. doi: 10.3748/wjg.v10.i20.3011
Group | f (V/V0) on days after irradiation | ||||
3 d | 6 d | 9 d | 2 d | 15 d | |
Control | 1.23 ± 0.37 | 3.11 ± 1.5 | 12.29 ± 4.83 | 20.21 ± 7.62 | 22.80 ± 8.50 |
20 Gy | 1.57 ± 0.19 | 2.34 ± 0.40 | 3.28 ± 0.68b | 4.18 ± 0.66b | 6.18 ± 1.40b |
PcDNA3.1 + 20 Gy | 1.86 ± 0.54 | 1.67 ± 0.40ad | 2.26 ± 0.50bd | 2.86 ± 0.58bd | 5.19 ± 0.66b |
PEgr-IFNγ | 1.38 ± 0.23 | 1.76 ± 0.56b | 2.61 ± 0.75b | 5.23 ± 0.98b | 8.03 ± 2.14b |
PEgr-IFNγ + 20 Gy | 0.48 ± 0.10bf | 0.34 ± 0.11bf | 0.38 ± 0.14bf | 0.43 ± 0.11bf | 0.35 ± 0.10bf |
-
Citation: Wu CM, Li XY, Huang TH. Anti-tumor effect of
pEgr-IFNγ gene-radiotherapy in B16 melanoma-bearing mice. World J Gastroenterol 2004; 10(20): 3011-3015 - URL: https://www.wjgnet.com/1007-9327/full/v10/i20/3011.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i20.3011